Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agile, Alx, Arrevus, Ascletis, Biocryst, Glaxosmithkline, Horizon, Jazz, Monopar, Novartis, Pharmamar, Roche.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Aravive, Axim, Azurrx, Bellerophon, Bioxcel, BMS, Eisai, Five Prime, Foamix, Mirati, Moleculin, Mustang, Ra, Recardio, Reneo, Sensorion.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acucela, Astellas, Celltrion Healthcare, Kubota, Noxopharm, Pfizer, Seattle Genetics, Takeda, TLC Co.
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Amarillo, Aptorum, Cipla, CNS Pharma, Codagenix, Cytodyn, Daewoong, Dr. Reddy’s, J&J, Jianjin University Haihe Hospital, Luye, M8 Pharma, Monash University, Recce, Synergy, Vir, Wockhardt, WPD Pharma, Xiamen Weiyang.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Prolung, Yourgene.